骨誘導因子(OGN)重組蛋白
Recombinant Osteoglycin (OGN)
OIF; SLRR3A; Mimecan Proteoglycan; Osteoinductive Factor
- 編號RPC688Mu02
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位n/a
- 預測分子量-
- 實際分子量-(差異分析請參閱說明書)
- 片段與標簽N-terminal His Tag
- 緩沖液成份磷酸鹽緩沖液（pH7.4，含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性狀凍干粉
- 純度> 97%
- 等電點-
- 應用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 739¥ 1848¥ 3696¥ 11088¥ 27720
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
PBS或其它。
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPC688Mu02 | 骨誘導因子(OGN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC688Mu01 | 骨誘導因子(OGN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC688Mu01 | 骨誘導因子(OGN)多克隆抗體 | WB; IHC |
| PAC688Mu02 | 骨誘導因子(OGN)多克隆抗體 | WB; IHC; ICC; IP. |
| LAC688Mu71 | 骨誘導因子(OGN)多克隆抗體(生物素標記) | WB |
| SEC688Mu | 骨誘導因子(OGN)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC688Mu | 骨誘導因子(OGN)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Bone. | Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus.[pubmed:27836731] |
| Tohoku journal of experimental medicine | Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.[pubmed:28824047] |
| Molecular Metabolism | Osteoglycin, a novel coordinator of bone and glucose homeostasis[Pubmed:29799418] |
| Journal of Experimental &?Clinical?Cancer?Research | Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway[Pubmed:29499765] |
| Journal of Human Hypertension | Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients[Pubmed:29867136] |
| Cell?Reports | Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue[Pubmed: 30332637] |
| J Clin Endocrinol Metab | Osteoglycin across the adult lifespan[34850904] |